Full name
WARSAW GENOMICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
47.91.Z - Retail sale via mail order houses or via Internet
68.20.Z - Rental and operating of own or leased real estate
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
70.2 - Management consultancy activities
70.22.Z - Business and other management consultancy activities
85.5 - Other education
85.60.Z - Educational support activities
86.2 - Medical and dental practice activities
86.90 - Other human health activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 3,8 | 0,3 | 0 | -93,8 |
Profit (loss) on sale | -0 | -0 | -0 | -121,9 |
Gross profit (loss) | 0,8 | -0 | -0 | -320,9 |
Net profit (loss) | 0,7 | -0 | -0 | -320,9 |
Cash | 3,8 | 0,3 | 0 | -95,1 |
Liabilities and provisions for liabilities | 1,2 | 0,3 | 0 | -90,8 |
Net income from sale | 0 | 0 | 0 | 0 |
Short time liabilities | 1,2 | 0,3 | 0 | -90,8 |
Other operating costs | 0 | 0 | 0 | -100 |
Working assets | 3,8 | 0,3 | 0 | -93,7 |
Equity capital | 2,6 | 0 | -0 | -419,9 |
% | % | % | p.p. | |
Profitability of capital | 27,5 | -99,8 | 131,3 | 231,1 |
Equity capital to total assets | 69,3 | 0,9 | -46 | -46,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 3.253716230392456 | 1.0018198490142822 | 0.6851292848587036 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane